Five University of California medical centers, including Moores Cancer Center at UC San Diego Health, have joined together to recruit 100,000 women in California to be part of the Women Informed to Screen Depending on Measures of Risk (WISDOM) clinical trial.

“Screening guidelines for breast cancer have changed many times over recent years and seem to be in a constant state of flux,” said Andrea Z. LaCroix, Ph.D., professor and chief of epidemiology in the department of Family Medicine and Public Health at University of California San Diego School of Medicine and co-principal investigator in the study. “The WISDOM trial’s goal is to test annual screening versus a personalized schedule based on a woman’s clinical and genetic risk factors for breast cancer. The study should determine which strategy produces the most benefit for women and the least harms.”

For more information visit www.wisdomstudy.org